Growth factor and receptor modulations in rat liver by choline-methionine deficiency

The Journal of Nutritional Biochemistry

Volumn 4, Issue 11, 1993, Pages 610-617

  Shinozuka, Hisashi ^a   Masuhara, Masaaki ^a   Kubo, Yoshitsugu ^a   Katyal, Sikandar L ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000554312     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/0955-2863(93)90031-Q     Document Type: Review

References (63)

1. Choline
2. Dietary choline: Biochemistry, physiology and pharmacology
3. Pathology of choline deficiency
4. The occurrence of neoplasms in the liver, lungs and other tissues of rats as a result of prolonged choline deficiency
5. Lipotropic factors and carcinogenesis
6. Dietary enhancement of intestinal carcinogenesis by dimethylhydrazine in rats
7. Methyl deficiency, DNA methylation and cancer: Studies on the reversibility of the effects of a lipotrope deficient diet
8. Choline deficiency, lipid peroxidation, liver cell surface receptor alterations and liver tumor promotion
9. 2 and C in rat liver without affecting the activation of protein kinase C
10. Liver regeneration: molecular mechanisms of growth control
11. Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the newborn animal
12. Epidermal growth factor
13. DNA synthesis in primary cultures of adult rat hepatocytes in defined medium: Effects of epidermal growth factor, insulin glucagon and cyclic AMP
14. Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences
15. Growth factors from murine sarcoma virus-transformed cells.
16. Heparin-binding growth factor type 1 (acidic fibroblast growth factor): potential biphasic autocrine and paracrine regulator of hepatocyte regeneration
17. Structure and function of hepatocyte growth factor
18. Purification and biological characterization of human hepatopoietin A, a polypeptide growth factor for hepatocytes
19. Hepatocyte growth factor: scatter factor: mitogen, motogen, and met
20. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor
21. Identification of hepatocyte growth factor receptor as the c-Met protooncogene product
22. Some recent advances in the chemistry and biology of transforming growth factor-beta
23. Transforming growth factor production by chemically transformed cells
24. Inhibitory effect of transforming growth factor-β on DNA synthesis of adult rat hepatocyte in culture
25. Inhibition of DNA synthesis in rat hepatocytes by platelet-derived type β transforming growth factor
26. Type β transforming growth factor irreversibly inhibits the early proliferative response to partial hepatectomy in the rat
27. Transforming growth factor β mRNA increases during liver regeneration: A possible paracrine mechanism of growth regulation
28. Transforming growth factor α(TGFα) may be a physiological regulator of liver regeneration via an autocrine mechanism
29. Marked increase of HGF mRNA in non-parenchymal liver cells of rats treated with hepatotoxin
30. Hepatocyte growth factor (Hepatopoietin A) rapidly increases in plasma before DNA synthesis and liver regeneration stimulated by partial hepatectomy and carbon tetrachloride administration
31. Expression of hepatocyte growth factor mRNA in regenerating rat liver after partial hepatectomy
32. Hormonal factors and liver growth
33. Extraction and partial purification of a hepatic stimulatory substance in rats, mice and dogs
34. Purification and physical-chemical characterization of hepatic stimulator substance
35. Partial purification of rat hepatic stimulator substance and characterization of its action on hepatoma cells and normal hepatocytes
36. Tumor necrosis factor stimulates DNA synthesis in the liver of intact rats
37. Tumor necrosis factor-α increases hepatic DNA and RNA and hepatocyte mitosis
38. Tumor necrosis factor and hepatic cell mass
39. Tumor necrosis factor stimulates DNA synthesis of mouse hepatocytes in primary culture and is suppressed by transforming growth factor β and interleukin 6
40. Lipid peroxidation of liver microsomal membranes induced by choline deficient diets and its relationship to the diet induced promotion of the induction of γ-glutamyltranspeptidase positive foci
41. Alterations in hepatocyte insulin receptors in rats fed a choline-deficient diet
42. Alterations induced by phenobarbital, a liver tumor promoter, in hepatocyte receptors for insulin and glucagon and glycogen metabolism
43. Modulation of epidermal growth factor receptors in rat hepatocytes by two liver tumor-promoting regimens; a choline deficient and a phenobarbital diet
44. Patterns of ligand binding to normal, regenerating preneoplastic and neoplastic rat hepatocytes
45. Role of insulin-stimulated protein phosphorylation in insulin action
46. Epidermal growth factor induces rapid tyrosine phosphorylation of protein in A431 human tumor cells
47. Studies on the role of cyclic AMP-dependent protein kinase in the action of glucagon and catecholamine on liver glycogen metabolism
48. Growth factors, oncogenes, and multistage carcinogenesis
49. Stimulation of DNA synthesis and cell proliferation in the liver of rats fed a choline devoid diet and their suppression by phenobarbital
50. Liver cell proliferation and incidence of hepatocellular carcinomas in rats fed consecutively a choline devoid and choline supplemented diet
51. Chemical carcinogenesis: too many rodent carcinogens
52. Pivotal role of increased cell proliferation in human carcinogenesis
53. Toxicity, cell proliferation and carcinogenesis
54. Differential expression of hepatocyte growth factor transforming factor α and transforming growth factor messenger RNAs in two experimental models of liver cell proliferation
55. Enhanced expression of hepatocyte growth factor and cMet mRNAs in isografts in experimental rat liver transplants
56. Expression of hepatocyte growth factor gene in endothelial and Kuppfer cells of damaged rat livers as revealed by in situ hybridization
57. Hepatocyte growth factor/hepatopoietin A is expressed in fat-storing cells from rat liver but not myofibroblast-like cells derived from fat-storing cells
58. Hepatocyte growth factor has potent anti-proliferative activity in various cell lines
59. Hepatocyte growth factor inhibits growth of hepatocellular carcinoma cells
60. Characterization of high molecular weight transforming growth factor .alpha. produced by rat hepatocellular carcinoma cells
61. 1 in liver carcinogenesis: Messenger RNA expression and growth effects
62. Transforming growth factor-β. Multiple actions and potential clinical applications
63. Lipotropes, immunocompetence and cancer